Update! Note the date as well!
$Cardiol Therapeutics (CRDL.US)$ Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis With Results to Be Presented at the American Heart Association Scientific Sessions 2024
newsfile·
Full clinical data will be reported in an oral presentation at the premier global event for advancements in cardiovascular science and medicine on November 18, 2024
newsfile·
Full clinical data will be reported in an oral presentation at the premier global event for advancements in cardiovascular science and medicine on November 18, 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
